N/A (Japanese healthy adults)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Those who have wrinkles mainly corresponding to Grade 1 to 3 on the outer corners of the eyes 2.Japanese healthy female aged 35 to 59 at the time of screening test 3.A person who has sufficiently explained about the test product and the purpose and contents of this test, and has obtained the written consent of the test subject to participate in the test voluntarily.
Exclusion criteria
Exclusion criteria: 1.Those who have a clear bias in left and right wrinkle grade 2.Those who have factors that affect the evaluation site (disease such as atopic dermatitis, trauma, burns, inflammation, acne, warts, or those traces) 3.Those who are currently visiting the hospital for a disease that has an affected area on their face 4.Those who have a history of allergies to cosmetics 5.People receiving hormone replacement therapy 6.Those who are pregnant or breastfeeding, or who wish to become pregnant during the period from the time of obtaining consent to the end of the study 7.Those who have experience in aesthetic medicine that affects the evaluation site, or those who plan to receive it during the test period 8.A person who has undergone a special skin care treatment (facial treatment, etc.) that affects the evaluation site from 4 weeks before the application of the test product, or a person who plans to receive it during the test period. 9.Those who continue to use cosmetics, health foods, etc. that advocate or appeal the efficacy related to this test to the evaluation site 10.A person who has received the test product in another clinical trial within 4 weeks after the test product is applied, or a person who plans to participate during the test period 11.In addition, those who are judged to be ineligible by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depth and safety of wrinkles around the eyes [1] Photo evaluation (wrinkle grade evaluation) [2] Equipment evaluation (3D analysis method by replica) [3] Doctor consultation (Safety assessment) | — |
Secondary
| Measure | Time frame |
|---|---|
| [1] Questionnaire (before pasting, after pasting) [2] Life diary (every day during the test period) | — |
Countries
Japan
Contacts
Medical Corporation Hokubukai Utsukushigaoka Hospital Center for Clinical Pharmacology